A pharmaceutical play, Novavax (NASDAQ:NVAX) has been on the move. In fact, NVAX stock has risen nearly three times higher since November of last year.
Source: Ascannio/Shutterstock.com
This leap is primarily due to the company’s Covid-19 vaccine inching closer to commercial release. However, despite the price appreciation, I believe there is still plenty of upside left for this name.
Here’s what you should know about NVAX stock moving forward.
NVAX Stock: An Important and Unique Vaccine
Recently, NVAX stock scored a major victory when the....More>>>